SCHEMBL7679170

SCHEMBL7679170

[c]1ccnc(N2CCOCC2)c1CNCCCN1CCOCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ KMT2A Q03164 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PAOX Q6QHF9 1/20 0.40
▸ KDM1A O60341 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ GAA P10253 2/20 0.38
▸ CDK4 P11802 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ RAD52 P43351 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7679097 0.95 CYP2C19 (0.48) CYP2C19CYP3A4CYP2D6KMT2AMEN1
SCHEMBL7675925 0.94 CYP2D6 (0.45) CYP2C19CYP3A4CYP2D6SMN1; SMN2KDM1A
SCHEMBL7681127 0.85 MKNK1 (0.40) CYP2C19CYP3A4CYP2D6KMT2AALDH1A1
SCHEMBL7672759 0.74 KDM4E (0.43) CYP2C19KMT2AMEN1SMN1; SMN2POLB
SCHEMBL7675540 0.71 HRH3 (0.46) CYP3A4ALDH1A1LMNA
SCHEMBL7677919 0.71 CYP2C19 (0.67) CYP2C19CYP3A4CYP2D6KMT2AMEN1
SCHEMBL3175221 0.70 CYP2C19 (0.80) CYP2C19CYP3A4CYP2D6KMT2AMEN1
SCHEMBL5596422 0.69 CDK4 (0.47) CYP2C19CYP3A4CYP2D6KMT2ASMN1; SMN2
SCHEMBL7675337 0.68 PIK3R1 (0.40) GAAKDM4ELMNA
SCHEMBL7673338 0.68 HRH3 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 — — US disclosed
Send feedback